Product Pathways - Lymphocyte Signaling
Ikaros (D6N9Y) Rabbit mAb (PE Conjugate) #33462
|33462S||100 µl ( 50 tests )||￥4,060.00||现货查询 购买询价 防伪查询|
|33462||carrier free & custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: F=Flow Cytometry,
Specificity / Sensitivity
Ikaros (D6N9Y) Rabbit mAb (PE Conjugate) recognizes endogenous levels of total Ikaros protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro329 of human Ikaros protein.
This Cell Signaling Technology antibody is conjugated to phycoerythrin (PE) and tested in-house for direct flow cytometry analysis in human cells. This antibody is expected to exhibit the same species cross-reactivity as the unconjugated Ikaros (D6N9Y) Rabbit mAb #14859.
The Ikaros family of zinc-finger DNA-binding proteins belongs to the Kruppel transcription factor superfamily. Ikaros proteins are characterized by the presence of an amino-terminal zinc finger DNA-binding domain and a carboxy-terminal dimerization domain. Members of the Ikaros family include Ikaros, Aiolos, Helios, EOS, and Pegasus (1). All family members can form homodimers and heterodimers with other members of the Ikaros family. Most also contain multiple isoforms that are generated as a result of differential splicing, with some isoforms behaving in a dominant negative manner upon dimerization (2).
Ikaros (IKZF1, LYF1) is the prototypical Ikaros family zinc-finger transcription factor and is expressed abundantly in lymphoid cells. Genetic studies in mice demonstrate that Ikaros is a tumor suppressor that is important for the normal development of B, T, natural killer, and dendritic cells (3,4). Additional studies show that imbalanced expression of different Ikaros isoforms, as well as mutations in the corresponding IKAROS gene, can be associated with a number of hematologic malignancies in humans (2,5,6).
- Perdomo, J. et al. (2000) J Biol Chem 275, 38347-54.
- Rebollo, A. and Schmitt, C. (2003) Immunol Cell Biol 81, 171-5.
- Georgopoulos, K. et al. (1997) Annu Rev Immunol 15, 155-76.
- Nichogiannopoulou, A. et al. (1998) Semin Immunol 10, 119-25.
- Tonnelle, C. et al. (2002) Leuk Lymphoma 43, 29-35.
- Martinelli, G. et al. (2009) J Clin Oncol 27, 5202-7.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
用户评论 --- 共 0 条